Moody’s downgrades Merck after hybrid bond
Moody’s downgraded Merck KGaA from A3 to Baa1 on Friday December 12, just four days after the German pharmaceutical company had issued €1.5bn of hybrid bonds as part of the funding of its acquisition of US life sciences company Sigma-Aldrich.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
